1. Home
  2. SBFM vs BRTX Comparison

SBFM vs BRTX Comparison

Compare SBFM & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$0.80

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$2.31

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
BRTX
Founded
2006
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Managed Health Care
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
3.7M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
SBFM
BRTX
Price
$0.80
$2.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
125.0K
★ 169.5K
Earning Date
04-03-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $36,305,891.00
$81,000.00
Revenue This Year
$40.47
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 4.11
N/A
52 Week Low
$0.25
$0.14
52 Week High
$3.05
$4.10

Technical Indicators

Market Signals
Indicator
SBFM
BRTX
Relative Strength Index (RSI) 28.87 56.12
Support Level $0.27 $0.22
Resistance Level $1.26 $2.93
Average True Range (ATR) 0.07 0.17
MACD -0.01 -0.08
Stochastic Oscillator 5.11 2.35

Price Performance

Historical Comparison
SBFM
BRTX

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Share on Social Networks: